SciTransfer
FORESEE · Project

Battery-free Implantable Sensors for Remote Heart Failure Monitoring

healthTestedTRL 5

Imagine a tiny sensor placed inside a blood vessel that doesn't need a battery to work. Instead, it gets its power wirelessly through the body from a device worn on the outside. This allows doctors to track heart health from a distance, catching problems before they lead to emergency hospital visits.

By the numbers
10.5 million
Heart failure patients in EU and US candidates for RPM
30,000
Annual cost of care per patient in US (USD)
50%
5-year mortality rate for chronic heart failure
1 mm
Maximum thickness of devices
The business problem

What needed solving

Chronic heart failure causes frequent, expensive hospitalizations and has a 50% five-year mortality rate. Current monitoring often lacks the miniaturization needed for seamless, long-term intravascular sensing.

The solution

What was built

A remote patient monitoring platform consisting of an intravascular microsensor, an external power/communication unit, a vascular delivery system, and a monitoring application.

Audience

Who needs this

Implantable medical device manufacturersCardiology clinic networksDigital health RPM startupsMedical insurance providers
Business applications

Who can put this to work

Medical Devices
enterprise
Target: Cardiovascular Implant Manufacturer

If you are a manufacturer dealing with the bulkiness of battery-powered implants — this project developed a microsensing platform that uses the human body as a conductor. This allows for thin, flexible devices under 1 mm that can be deployed in the vascular tree.

Digital Health
mid-size
Target: Remote Patient Monitoring (RPM) Service Provider

If you are a provider dealing with the high cost of heart failure hospitalizations — this project developed an external unit and app that monitors patient status wirelessly. This helps manage the 10.5 million candidates for RPM in the EU and US.

Healthcare Systems
enterprise
Target: Private Hospital Network

If you are a hospital network dealing with annual care costs of US$30,000 per heart failure patient — this project developed a miniaturized sensor for pulmonary artery pressure. This optimizes medical management and reduces frequent hospitalizations.

Frequently asked

Quick answers

What is the cost impact of the condition this device treats?

Chronic heart failure leads to annual care costs exceeding US$30,000 per patient in the US.

How is the device scaled for the patient's body?

The technology achieves extreme miniaturization, creating devices thinner than 1 mm that lack bulky components or batteries.

What is the IP or licensing status of the technology?

Based on available project data, the project is focused on moving from TRL3 to TRL5 and developing a business strategy for market access, but specific patent numbers are not listed.

What regulations are being followed for development?

The team has implemented a traceability matrix based on ISO 13485 to define design input and output requirements.

What is the timeline for market readiness?

The project runs from December 2023 to November 2026, aiming to reach TRL5 by the end of the period.

Consortium

Who built it

The project is currently led by a single academic partner, Universidad Pompeu Fabra in Spain. With 0% industry representation in the consortium, the project is heavily research-driven, though it explicitly includes the development of a business strategy to bridge the gap to market.

How to reach the team

Contact the research office at Universidad Pompeu Fabra

Next steps

Talk to the team behind this work.

Contact us to find licensing opportunities for this battery-free sensing platform.

More in Health & Biomedical
See all Health & Biomedical projects